申请人:Machinaga Nobuo
公开号:US08653126B2
公开(公告)日:2014-02-18
To provide a novel compound or an isotope thereof or a pharmaceutically acceptable salt thereof having S1P lyase inhibitory capacity and inducing the decrease in number of lymphocytes, and a pharmaceutical composition containing these as active ingredients. A compound represented by the general formula (I):
or the general formula (II):
or an isotope thereof or a pharmaceutically acceptable salt thereof.
提供一种具有S1P裂解酶抑制能力并诱导淋巴细胞数量减少的新化合物或其同位素或其药学上可接受的盐,并包含这些化合物作为活性成分的制药组合物。化合物的一般式(I)或一般式(II),或其同位素或其药学上可接受的盐。